Jennifer Martin and Dan Rogers Added to the Omnia Medical Team: Martin to Lead the Interventional Pain Therapies Division Alongside Thomas Batton and Dan Rogers

VERITAS Vision System Is Introduced by Johnson & Johnson

The company will offer live demos of the new system in a wet lab at the Johnson & Johnson booth (#2813) this weekend at the 2021 American Society of Cataract and Refractive Surgery and American Society of Ophthalmic Administrators Annual Meeting.

GenesisCare Orders 27 Elekta Flexitron Treatment Devices

"GenesisCare continues to demonstrate its commitment to improving patient outcomes worldwide and Elekta is delighted to play a vital partnering role to achieve this mission," said Gustaf Salford, Elekta's President and CEO.

FoodMarble AIRE Shown to Exceed the Performance of ‘Gold Standard’ SIBO Testing in Clinical Trial

SIBO is a very common disorder where there are excessive bacteria present in the small intestine. The true prevalence of SIBO in the general population is largely unknown, with some studies estimating its occurrence in up to 15% of healthy individuals. It is also largely associated with many other common clinical conditions, including irritable bowel syndrome, where 40-80% of IBS patients have SIBO.

December 30, 2020

Jennifer Martin and Dan Rogers have been added to the Omnia Medical team.

Jennifer Martin will lead Omnia Medical’s Interventional Pain Therapies Division alongside Thomas Batton and Dan Rogers.

The new team members will be crucial in the expansion of Omnia Medical and the launch of a new division created for the sole focus of helping Pain Management Specialists provide leading-edge care to patients with debilitating pain due to Sacroiliac (SI) joint dysfunction.

Jennifer Martin, President of the new Interventional Pain Therapies division, brings over 15 years of experience in product training and market development. Most recently she served as Senior Director of Customer Engagement at Boston Scientific. Prior to her time at Boston Scientific, she served as CEO of Next Level Interactive, Sr. Director of Field and Physician Development at St. Jude Medical, and Vice President of Global Sales Training at KCI Medical.

Ms. Martin will be working closely with Dan Rogers as he joins Omnia Medical as the Vice President of Sales for the new division. He most recently served as Regional Sales Director at Boston Scientific and Vertiflex. With more than a decade of experience, Dan Rogers will join Thomas Batton and Sean Herd in working closely with Ms. Martin to grow and further advance technologies within the Interventional Pain Therapies division.

“I am incredibly excited to join Omnia Medical. The Company has a unique opportunity to accelerate an already impressive growth trajectory and become the posterior SI joint fusion system of choice for interventional pain management physicians and spine surgeons. I look forward to working with our Omnia Medical team and applying my experience and deep understanding of market development and growth for medical device companies.” – Jennifer Martin, President of Omnia Medical’s Interventional Pain Therapies division.

This new division will provide a strong collaboration between Spine Surgeons and Pain Management Specialists when diagnosing accurate patient pathology as spine related or SI joint dysfunction. This collaboration will further provide an opportunity for Pain Management Specialists to integrate SI joint fusion technologies in their treatment algorithm for patients.

The launch of the new division comes at a critical time when providers are increasingly focused on delivering a more comprehensive range of therapies. Omnia Medical is combining its research and development expertise with manufacturing experience to provide minimally invasive solutions tailored specifically to Pain Management Specialists.

spot_img

DON'T MISS

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.